Biotech company Abivax announces the appointment of Marc de Garidel as CEO and interim Chairman of its Board of Directors, effective May 5, with a new Chairman to be appointed in the course of 2023.

Corinna zur Bonsen-Thomas retires from her position as Chairman, which she has held since August 2022, and remains a member of the Board of Directors. Hartmut J Ehrlich is stepping down as CEO, a position he has held since the creation of Abivax.

'After joining CinCor Pharma in July 2021, Marc de Garidel successfully completed the sale of this company to AstraZeneca in February 2023 for up to $1.8 billion', depending on milestone payments, the company points out.

Copyright (c) 2023 CercleFinance.com. All rights reserved.